Vectiopep
Entity

  • Vectiopep

    Created in 2022


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    467

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Tartu, Estonia

    Tartu

    Estonia

  • Employees

    Scale: 2-10

    Estimated: 5

  • Engaged catalyst

    0
    0 0

  • Added in Motherbase

    3 months, 2 weeks ago
Description
  • Value proposition

    We develop cancer immunotherapy with our unique mRNA delivery technology

    Vectiopep is developing peptide-based nucleic acid delivery technology. Combined with the new generation mRNA therapeutics, we empower the body's immune system to fight cancer.

    Vectiopep is a privately-held biotechnology company, founded by a group of researchers who have more than 10 years of expertise in developing and optimizing delivery technologies for nucleic acids..

Catalyst interactions
Catalyst Type Tweets Articles
No interactions
Social network dynamics
Similar entities
BETA
Last news
Show all articles